Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Osteosarcoma × Ipilimumab × Clear all

Phase

Status

Sponsor Class

OTHER 2 OTHER_GOV 1 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Uveal Melanoma 2 Sarcoma 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Melanoma 1 Gastrointestinal Stromal Tumors 1 Desmoplastic Small Round Cell Tumor 1 Chondrosarcoma 1 Bone Neoplasms 1

Interventions

spartalizumab 1 apatinib 1 Zoledronic Acid 1 Nivolumab 1 Ipilimumab 1 Ifosfamide 1 Doxorubicin 1 Ashwagandha 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02982486 2017-11-01

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Assaf-Harofeh Medical Center

Phase 2 Unknown

GastrointestinalSarcoma

Bone Neoplasms, Chondrosarcoma, Sarcoma, Osteosarcoma, Gastrointestinal Stromal Tumors, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡